Cargando…
NTRK1 Fusion in Glioblastoma Multiforme
Glioblastoma multiforme (GBM) is the most aggressive form of brain tumor, yet with no targeted therapy with substantial survival benefit. Recent studies on solid tumors showed that fusion genes often play driver roles and are promising targets for pharmaceutical intervention. To survey potential fus...
Autores principales: | Kim, Jinkuk, Lee, Yeri, Cho, Hee-Jin, Lee, Young-Eun, An, Jaeyeol, Cho, Gye-Hyun, Ko, Young-Hyeh, Joo, Kyeung Min, Nam, Do-Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960150/ https://www.ncbi.nlm.nih.gov/pubmed/24647444 http://dx.doi.org/10.1371/journal.pone.0091940 |
Ejemplares similares
-
Correction: NTRK1 Fusion in Glioblastoma Multiforme
Publicado: (2014) -
Talin1 targeting potentiates anti-angiogenic therapy by attenuating invasion and stem-like features of glioblastoma multiforme
por: Kang, Wonyoung, et al.
Publicado: (2015) -
Chemoradiotherapy Alters Protein Expression in Glioblastoma Multiforme
por: Hwang, Mina, et al.
Publicado: (2020) -
Translational Validation of Personalized Treatment Strategy Based on Genetic Characteristics of Glioblastoma
por: Oh, Young Taek, et al.
Publicado: (2014) -
Correction: The Synergistic Local Immunosuppressive Effects of Neural Stem Cells Expressing Indoleamine 2,3-Dioxygenase (IDO) in an Experimental Autoimmune Encephalomyelitis (EAE) Animal Model
por: Lee, Young Eun, et al.
Publicado: (2016)